1. #1

    Testosterone Prescriptions Declined after FDA Warning

    A new study published in JAMA found that testosterone prescriptions fell sharply after the FDA issued a warning that testosterone increases the risk of cardiovascular disease. A news article says:

    By reviewing health insurance records for almost 10 million men aged 30 and older, the investigators found that total testosterone use increased from 0.52 percent of men in 2002 to 3.2 percent in 2013. But 2013 was the year in which the "low-T" wave crested. After that, the popularity of testosterone therapy waned sharply, falling to less than 2 percent of men by 2016. The decline in overall use of testosterone appears linked to an advisory put out by the U.S. Food and Drug Administration in 2013, the researchers said. The FDA advisory warned that men using testosterone to ward off aging might be putting themselves at increased risk of a heart attack or stroke.

    Name:  Testosterone prescriptions.jpg
Views: 113
Size:  63.2 KB

    The decline is celebrated by a doctor:

    The decrease is "definitely a good thing," said Dr. Shalender Bhasin, an endocrinologist with Brigham and Women's Hospital in Boston.

    "It's a hopeful sign that educational efforts in science do matter, and people pay attention to both the science and the information from clinical studies that's being put out by scientists," said Bhasin. He chairs the Endocrine Society's testosterone guidelines committee.
    Except that in this case the science was wrong and the public misinformed.
    Last edited by Nelson Vergel; 07-17-2018 at 10:31 AM.

  2. # ADS
    Purchase From Our Affiliates
    Join Date
    Help Excelmale


  3. #2
    Member Sean Mosher's Avatar
    Join Date
    Nov 2015
    Houston, Texas
    If having low testosterone is so normal then why did previous generations have so much higher levels..........did they all suffer/die from cardiovascular disease too??

  4. #3
    Name:  t_users.jpg
Views: 133
Size:  63.2 KB

    A plot of TRT users from the article.
    Last edited by Nelson Vergel; 07-17-2018 at 10:31 AM.

  5. #4
    This is big pharma is pushing back, now they can sell more **** pills.

  6. #5
    Super Moderator Nelson Vergel's Avatar
    Join Date
    Sep 2013
    Houston, Texas, United States
    The state of testosterone therapy since the FDA's 2015 labeling changes: Indications and cardiovascular risk

    A label change in testosterone (T) products in March 2015 followed a highly publicized FDA advisory committee meeting in September 2014. Changes included a warning of possible increased cardiovascular (CV) risks and restriction of indicated populations to younger men with a limited set of known aetiologies of testosterone deficiency (TD). These changes greatly impacted clinical practice and public perception of T therapy (TTh). Our aim was to review these changes in the light of subsequently published studies.

    We identified 23 studies through June 2017, including 12 clinical trials and 11 observational studies. The Testosterone Trials included 790 men aged 65 years and older with TD without known aetiology, assigned to 1‐year T gel or placebo.

    Demonstrated benefits of T included sexual activity and desire, physical activity and mood. There were 9 major adverse CV events (MACE) in the T arm and 16 in the placebo arm. No study reported increased MACE with TTh. A 3‐year RCT showed no difference in carotid atherosclerosis. Several large observational studies reported reduced CV events with TTh, including one showing progressively reduced CV and mortality risk with greater duration of TTh. Men whose serum T normalized with TTh had reduced risk of MI and death compared with men whose T levels failed to normalize.

    We conclude that existing evidence fails to support increased CV risk with TTh; on the contrary, there is evidence suggestive of real‐world CV benefits. Finally, existing evidence provides benefits of TTh in older men without known aetiology for T deficiency.


  7. #6
    Super Moderator Nelson Vergel's Avatar
    Join Date
    Sep 2013
    Houston, Texas, United States
    We are seeing an increase already, especially in compounded testosterone prescriptions. The graph above does not include prescriptions from the compounding industry.

Thread Information

Users Browsing this Thread

There are currently 1 users browsing this thread. (0 members and 1 guests)

Similar Threads

  1. Tlando Oral Testosterone Not Approved by the FDA
    By Jinzang in forum Resources and Suppliers
    Replies: 1
    Last Post: 05-09-2018, 12:44 PM
  2. Two New Testosterone Formulations Flunk FDA Panel
    By Jinzang in forum Resources and Suppliers
    Replies: 1
    Last Post: 01-11-2018, 08:14 AM
  3. FDA adds abuse warning to testosterone
    By Henry in forum Testosterone Basics & Questions
    Replies: 3
    Last Post: 10-27-2016, 08:35 PM
  4. FDA requires new warning label on testosterone
    By Jinzang in forum Testosterone Basics & Questions
    Replies: 0
    Last Post: 10-26-2016, 05:36 AM
  5. Group Urges FDA To Add Boxed Warning To Testosterone Drugs.
    By Jasen Bruce in forum Testosterone Basics & Questions
    Replies: 1
    Last Post: 02-25-2014, 01:14 PM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts